AstraZeneca

In News

AstraZeneca reprimanded over LinkedIn likes once again - Fierce Pharma

Fierce Pharma - Jun 09, 2026

Type 2 Diabetes: AstraZeneca's New Oral GLP-1 Led to 10.5% Weight Loss - Healthline

Healthline - Jun 09, 2026

Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected? - The Guardian

The Guardian - Jun 10, 2026

Gilead and Merck’s latest trial success and flop - statnews.com

statnews.com - Jun 09, 2026

LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials - Yahoo Finance

Yahoo Finance - Jun 08, 2026

Hong Kong's urban development near China border draws AstraZeneca, others - Nikkei Asia

Nikkei Asia - Jun 08, 2026

Analyst James Quigley Reiterates Buy on AstraZeneca, Citing Undervalued Pipeline‑Driven Growth Upside - TipRanks

TipRanks - Jun 10, 2026

Pancreatic cancer trial sees 22.3‑month survival gain in select patients - Stock Titan

Stock Titan - Jun 08, 2026

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success - CNBC

CNBC - Jun 05, 2026

FDA approves AstraZeneca’s new kind of hypertension drug - BioPharma Dive

BioPharma Dive - May 18, 2026

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio - AstraZeneca

AstraZeneca - Jun 08, 2026

AstraZeneca GLP-1 pill shows promise in obesity, diabetes trials | STAT - statnews.com

statnews.com - Jun 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment